These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
882 related items for PubMed ID: 17270621
1. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy. Margel D, Tal R, Golan S, Kedar D, Engelstein D, Baniel J. Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621 [Abstract] [Full Text] [Related]
2. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED. J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480 [Abstract] [Full Text] [Related]
14. Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment. Okamura T, Akita H, Imura M, Kaneko T, Mizuno K, Tozawa K, Kohri K. Int J Urol; 2008 Oct; 15(11):976-80. PubMed ID: 18721199 [Abstract] [Full Text] [Related]
15. Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder. Zhang GK, Uke ET, Sharer WC, Borkon WD, Bernstein SM. J Urol; 1996 Jun; 155(6):1907-9. PubMed ID: 8618284 [Abstract] [Full Text] [Related]
17. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. BJU Int; 2007 Jul; 100(1):33-6. PubMed ID: 17552951 [Abstract] [Full Text] [Related]
18. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis. Uchida A, Yonou H, Hayashi E, Iha K, Oda M, Miyazato M, Oshiro Y, Hokama S, Sugaya K, Ogawa Y. Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663 [Abstract] [Full Text] [Related]
19. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Böhle A, Bock PR. Urology; 2004 Apr; 63(4):682-6; discussion 686-7. PubMed ID: 15072879 [Abstract] [Full Text] [Related]
20. High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG). Pansadoro V, Emiliozzi P, depaula F, Scarpone P, Pizzo M, Federico G, Martini M, Pansadoro A, Sternberg CN. J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):223-7. PubMed ID: 16767936 [Abstract] [Full Text] [Related] Page: [Next] [New Search]